Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q415032> ?p ?o }
Showing triples 1 to 71 of
71
with 100 triples per page.
- Q415032 subject Q22230916.
- Q415032 subject Q8808791.
- Q415032 subject Q8862272.
- Q415032 subject Q8873325.
- Q415032 abstract "Eletriptan (trade name Relpax, used in the form of eletriptan hydrobromide) is a second generation triptan drug intended for treatment of migraine headaches. It is used as an abortive medication, blocking a migraine attack which is already in progress. Eletriptan is marketed and manufactured by Pfizer Inc. It is sold in the US and Canada under the brand name Relpax, and in several other countries under the brand name Relert.".
- Q415032 atcPrefix "N02".
- Q415032 atcSuffix "CC06".
- Q415032 bioavailability "50.0".
- Q415032 casNumber "143322-58-1".
- Q415032 chEBI "50922".
- Q415032 drugbank "DB00216".
- Q415032 fdaUniiCode "22QOO9B8KI".
- Q415032 iupacName "(R)-3-[(-1-methylpyrrolidin-2-yl)methyl]-5-(2-phenylsulfonylethyl)- 1H-indole".
- Q415032 pubchem "77993".
- Q415032 thumbnail Eletriptane_Structural_Formulae.png?width=300.
- Q415032 wikiPageExternalLink 990.
- Q415032 wikiPageExternalLink a603029.html.
- Q415032 wikiPageExternalLink rx-mono.aspx?contentFileName=rel1663.html&contentName=Relpax&contentId=649.
- Q415032 wikiPageExternalLink www.relpax.com.
- Q415032 wikiPageWikiLink Q12140.
- Q415032 wikiPageWikiLink Q133823.
- Q415032 wikiPageWikiLink Q14864419.
- Q415032 wikiPageWikiLink Q1540899.
- Q415032 wikiPageWikiLink Q16.
- Q415032 wikiPageWikiLink Q179661.
- Q415032 wikiPageWikiLink Q18027423.
- Q415032 wikiPageWikiLink Q180762.
- Q415032 wikiPageWikiLink Q181754.
- Q415032 wikiPageWikiLink Q204711.
- Q415032 wikiPageWikiLink Q206921.
- Q415032 wikiPageWikiLink Q209583.
- Q415032 wikiPageWikiLink Q213511.
- Q415032 wikiPageWikiLink Q22230916.
- Q415032 wikiPageWikiLink Q30.
- Q415032 wikiPageWikiLink Q334477.
- Q415032 wikiPageWikiLink Q3355478.
- Q415032 wikiPageWikiLink Q389934.
- Q415032 wikiPageWikiLink Q407883.
- Q415032 wikiPageWikiLink Q41861.
- Q415032 wikiPageWikiLink Q423866.
- Q415032 wikiPageWikiLink Q424432.
- Q415032 wikiPageWikiLink Q663360.
- Q415032 wikiPageWikiLink Q7189656.
- Q415032 wikiPageWikiLink Q739481.
- Q415032 wikiPageWikiLink Q7455050.
- Q415032 wikiPageWikiLink Q753583.
- Q415032 wikiPageWikiLink Q816759.
- Q415032 wikiPageWikiLink Q86.
- Q415032 wikiPageWikiLink Q8808791.
- Q415032 wikiPageWikiLink Q8862272.
- Q415032 wikiPageWikiLink Q8873325.
- Q415032 wikiPageWikiLink Q908843.
- Q415032 wikiPageWikiLink Q9368.
- Q415032 wikiPageWikiLink Q9377.
- Q415032 atcPrefix "N02".
- Q415032 atcSuffix "CC06".
- Q415032 bioavailability "50.0".
- Q415032 casNumber "143322".
- Q415032 chebi "50922".
- Q415032 drugbank "DB00216".
- Q415032 iupacName "-3".
- Q415032 pubchem "77993".
- Q415032 unii "22".
- Q415032 type ChemicalSubstance.
- Q415032 type Drug.
- Q415032 type ChemicalObject.
- Q415032 type Thing.
- Q415032 type Q8386.
- Q415032 comment "Eletriptan (trade name Relpax, used in the form of eletriptan hydrobromide) is a second generation triptan drug intended for treatment of migraine headaches. It is used as an abortive medication, blocking a migraine attack which is already in progress. Eletriptan is marketed and manufactured by Pfizer Inc. It is sold in the US and Canada under the brand name Relpax, and in several other countries under the brand name Relert.".
- Q415032 label "Eletriptan".
- Q415032 depiction Eletriptane_Structural_Formulae.png.
